Journal of Urologic Oncology

Prostate Cancer

The Integral Role and Clinical Significance of Metabolic Profiling in Prostate Cancer: A Narrative Review: Valentin Nikolaevich Pavlov, Marat Fayazovich Urmantsev, Marat Radikovich Bakeev, Olalekan Samuel Akinyemi; Journal of Urologic Oncology. 2024;22(2):150-156. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800260013
Cited By 1; Full text PubReader ePub PDF

Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma: Jeong Yoon Suh, Se Jung Maeng, Mirinae Kim, Su Jeong Kang, Young Wook Choi, In Ho Chang; Korean J Urol Oncol. 2022;20(4):223-234. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.223
Cited By 1; Full text PubReader ePub PDF

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer: Ja Yoon Ku, Eu Chang Hwang, Chan Ho Lee, Kyung Hwan Kim, Dong Deuk Kwon, Hong Koo Ha; Korean J Urol Oncol. 2022;20(1):52-58. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.52
Correction in: 2023;21(3):277; Full text PubReader ePub PDF

Clinical Implications of Urinary Microbiome in Bladder Cancer: Jae Hun Shim, Joon Hee Gook, In Ho Chang, Jung Min Sohn, Sin Woo Seong, Byung Hoon Chi; Korean J Urol Oncol. 2021;19(2):71-78. Published online May 31, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.2.71; Full text PubReader ePub PDF

Potential Utility of Prostate Health Index Density for Prostate Cancer Detection and Prediction in Korean Men: A Prospective Multicenter Study: Geehyun Song, Hongzoo Park, Sang Wook Lee, Tae Wook Kang, Jae Hung Jung, Hyun Chul Chung, Sung Jin Kim, Jong Yeon Park, Jeong Hyun Kim; Korean J Urol Oncol. 2020;18(2):147-154. Published online August 27, 2020; DOI: https://doi.org/10.22465/kjuo.2020.18.2.147; Full text PubReader ePub PDF

Next-Generation Sequencing in Prostate Cancer: Seong Hyeon Yu, Taek Won Kang; Korean J Urol Oncol. 2020;18(1):18-23. Published online April 29, 2020; DOI: https://doi.org/10.22465/kjuo.2020.18.1.18; Full text PubReader ePub PDF

Developing Biomarkers and New Therapeutic Targets in Muscle Invasive Bladder Cancer: Yun-Sok Ha; Korean J Urol Oncol. 2020;18(1):1-10. Published online April 29, 2020; DOI: https://doi.org/10.22465/kjuo.2020.18.1.1
Cited By 1; Full text PubReader ePub PDF

Predictive Molecular and Protein Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer: Won Tae Kim, Seok Joong Yun, Wun-Jae Kim; Korean J Urol Oncol. 2019;17(2):81-87. Published online August 30, 2019; DOI: https://doi.org/10.22465/kjuo.2019.17.2.81; Full text PubReader ePub PDF

NBR1 and KIF14 Downstream of the Mammarian Target of Rapamycin Pathway Predict Recurrence in Nonmuscle Invasive Low Grade Urothelial Carcinoma of the Bladder: Dong-Gi Lee, Ha Jeong Kim, Subin Jin, Jin Wook Kim, Young Mi Whang, Tae-Jin Lee, In Ho Chang; Korean J Urol Oncol. 2017;15(1):28-37. Published online April 26, 2017; DOI: https://doi.org/10.22465/kjuo.2017.15.1.28
Cited By 2; Full text PubReader ePub PDF Supplementary Material

The Correlation of Tissue-Based Biomarkers in Primary and Metastatic Renal Cell Carcinoma Lesions: A Tissue Microarray Study: Sung Han Kim, Weon Seo Park, Eun Young Park, Boram Park, Jungnam Joo, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung; Korean J Urol Oncol. 2016;14(3):152-158. Published online December 31, 2016; DOI: https://doi.org/10.22465/kjuo.2016.14.3.152
Cited By 4; Full text PubReader ePub PDF Supplementary Material

High Notch1 Expression Correlates with Tumor Stage and Size in Clear Cell Renal Cell Carcinoma: Jun Nyung Lee, So Young Chun, Hyo Jung Lee, Yun-Sok Ha, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Tae-Hwan Kim; Korean J Urol Oncol. 2016;14(3):130-137. Published online December 31, 2016; DOI: https://doi.org/10.22465/kjuo.2016.14.3.130
Cited By 3; Full text PubReader ePub PDF

Clinical Utility of Novel Biomarkers in the Era of Active Surveillance of Prostate Cancer: Jeong Hyun Kim; Korean J Urol Oncol. 2015;13(2):58-65. Published online August 30, 2015; PDF

Molecular Markers for Prostate Cancer; Current Status and Future Directions: Seok Ho Kang; Korean J Urol Oncol. 2008;6(2):74-86. Published online August 30, 2008; PDF

6,025	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,499	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
5,005	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,841	Complex Epidemiology of Prostate Cancer in Asian Countries
4,691	The Present and Future of Intravesical Therapy in Bladder Cancer

Cited By 9	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Search